APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polypeptide Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Polypeptide Drug Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchPolypeptide Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Polypeptide Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Polypeptide Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polypeptide Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Polypeptide Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Polypeptide Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Polypeptide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Polypeptide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polypeptide Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Polypeptide Drug include Takeda, Sanofi, Novartis, Roche, Lilly, Ferring Pharmaceuticals, AstraZeneca, SciClone Pharmaceuticals and Merck Serono, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Polypeptide Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Polypeptide Drug market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Polypeptide Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Polypeptide Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Polypeptide Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Polypeptide Drug Market by Company

Takeda

Sanofi

Novartis

Roche

Lilly

Ferring Pharmaceuticals

AstraZeneca

SciClone Pharmaceuticals

Merck Serono

Ipsen PHarma Biotech

Asahi Kasei

Polypeptide Drug Segment by Type

Injection

Oral Administration

Transdermal Administration

Lung Administration

Nasal Administration

Polypeptide Drug Segment by Application

Tumor Drug

Digestive System Drugs (Gastrointestinal Type)

Immunity Regulating Medicine (Allergy Infection and Immune)

Urinary System Drug

Bone and Connective Tissue Types (Thyroid hormones Drug)

Gynecologic or Obstetric Drug

Metabolic Drug (Insulin and Other Hypoglycemic Agents)

Polypeptide Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polypeptide Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polypeptide Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polypeptide Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Polypeptide Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Polypeptide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Oral Administration Table 3. Major Company of Transdermal Administration Table 4. Major Company of Lung Administration Table 5. Major Company of Nasal Administration Table 6. Global Polypeptide Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 8. Global Polypeptide Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Polypeptide Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Polypeptide Drug Price by Type (2021-2026) & (US$/Ton) Table 12. Global Polypeptide Drug Sales by Type (2027-2032) & (Tons) Table 13. Global Polypeptide Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Polypeptide Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Polypeptide Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Polypeptide Drug Price by Type (2027-2032) & (US$/Ton) Table 17. North America Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 18. North America Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 20. Europe Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 22. Asia-Pacific Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 24. Latin America Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Polypeptide Drug Sales by Type (2021-2026) & (Tons) Table 26. Middle East and Africa Polypeptide Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Polypeptide Drug Industry Trends Table 28. Polypeptide Drug Industry Drivers Table 29. Polypeptide Drug Industry Opportunities and Challenges Table 30. Polypeptide Drug Industry Restraints Table 31. Global Polypeptide Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Polypeptide Drug Revenue Market Share by Company (2021-2026) Table 33. Global Polypeptide Drug Sales by Company (2021-2026) & (Tons) Table 34. Global Polypeptide Drug Sales Share by Company (2021-2026) Table 35. Global Polypeptide Drug Market Price by Company (2021-2026) & (US$/Ton) Table 36. Global Polypeptide Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Polypeptide Drug Major Company Production Sites and Headquarters Table 38. Global Polypeptide Drug Company, Product Type & Application Table 39. Global Polypeptide Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Polypeptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Polypeptide Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Polypeptide Drug Sales by Region (2021-2026) & (Tons) Table 44. Global Polypeptide Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Polypeptide Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Polypeptide Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Polypeptide Drug Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Global Polypeptide Drug Sales by Region (2027-2032) & (Tons) Table 49. Global Polypeptide Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Polypeptide Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Polypeptide Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Polypeptide Drug Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 53. Global Polypeptide Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 55. Global Polypeptide Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Polypeptide Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Polypeptide Drug Price by Application (2021-2026) & (US$/Ton) Table 59. Global Polypeptide Drug Sales by Application (2027-2032) & (Tons) Table 60. Global Polypeptide Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Polypeptide Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Polypeptide Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Polypeptide Drug Price by Application (2027-2032) & (US$/Ton) Table 64. North America Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 65. North America Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 67. Europe Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 69. Asia-Pacific Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 71. Latin America Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Polypeptide Drug Sales by Application (2021-2026) & (Tons) Table 73. Middle East and Africa Polypeptide Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Takeda Polypeptide Drug Product Portfolio Table 78. Takeda Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Sanofi Polypeptide Drug Product Portfolio Table 83. Sanofi Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Novartis Polypeptide Drug Product Portfolio Table 88. Novartis Recent Development Table 89. Roche Company Information Table 90. Roche Business Overview Table 91. Roche Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Roche Polypeptide Drug Product Portfolio Table 93. Roche Recent Development Table 94. Lilly Company Information Table 95. Lilly Business Overview Table 96. Lilly Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Lilly Polypeptide Drug Product Portfolio Table 98. Lilly Recent Development Table 99. Ferring Pharmaceuticals Company Information Table 100. Ferring Pharmaceuticals Business Overview Table 101. Ferring Pharmaceuticals Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Ferring Pharmaceuticals Polypeptide Drug Product Portfolio Table 103. Ferring Pharmaceuticals Recent Development Table 104. AstraZeneca Company Information Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. AstraZeneca Polypeptide Drug Product Portfolio Table 108. AstraZeneca Recent Development Table 109. SciClone Pharmaceuticals Company Information Table 110. SciClone Pharmaceuticals Business Overview Table 111. SciClone Pharmaceuticals Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. SciClone Pharmaceuticals Polypeptide Drug Product Portfolio Table 113. SciClone Pharmaceuticals Recent Development Table 114. Merck Serono Company Information Table 115. Merck Serono Business Overview Table 116. Merck Serono Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Merck Serono Polypeptide Drug Product Portfolio Table 118. Merck Serono Recent Development Table 119. Ipsen PHarma Biotech Company Information Table 120. Ipsen PHarma Biotech Business Overview Table 121. Ipsen PHarma Biotech Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Ipsen PHarma Biotech Polypeptide Drug Product Portfolio Table 123. Ipsen PHarma Biotech Recent Development Table 124. Asahi Kasei Company Information Table 125. Asahi Kasei Business Overview Table 126. Asahi Kasei Polypeptide Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Asahi Kasei Polypeptide Drug Product Portfolio Table 128. Asahi Kasei Recent Development Table 129. North America Polypeptide Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 130. North America Polypeptide Drug Sales by Country (2021-2026) & (Tons) Table 131. North America Polypeptide Drug Sales Market Share by Country (2021-2026) Table 132. North America Polypeptide Drug Sales Forecast by Country (2027-2032) & (Tons) Table 133. North America Polypeptide Drug Sales Market Share Forecast by Country (2027-2032) Table 134. North America Polypeptide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Polypeptide Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Polypeptide Drug Market Share by Country (2021-2026) Table 137. North America Polypeptide Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Polypeptide Drug Market Share Forecast by Country (2027-2032) Table 139. Europe Polypeptide Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 140. Europe Polypeptide Drug Sales by Country (2021-2026) & (Tons) Table 141. Europe Polypeptide Drug Sales Market Share by Country (2021-2026) Table 142. Europe Polypeptide Drug Sales Forecast by Country (2027-2032) & (Tons) Table 143. Europe Polypeptide Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Polypeptide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Polypeptide Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Polypeptide Drug Market Share by Country (2021-2026) Table 147. Europe Polypeptide Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Polypeptide Drug Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Polypeptide Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Polypeptide Drug Sales by Country (2021-2026) & (Tons) Table 151. Asia-Pacific Polypeptide Drug Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Polypeptide Drug Sales Forecast by Country (2027-2032) & (Tons) Table 153. Asia-Pacific Polypeptide Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Polypeptide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Polypeptide Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Polypeptide Drug Market Share by Country (2021-2026) Table 157. Asia-Pacific Polypeptide Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Polypeptide Drug Market Share Forecast by Country (2027-2032) Table 159. Latin America Polypeptide Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 160. Latin America Polypeptide Drug Sales by Country (2021-2026) & (Tons) Table 161. Latin America Polypeptide Drug Sales Market Share by Country (2021-2026) Table 162. Latin America Polypeptide Drug Sales Forecast by Country (2027-2032) & (Tons) Table 163. Latin America Polypeptide Drug Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Polypeptide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Polypeptide Drug Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Polypeptide Drug Market Share by Country (2021-2026) Table 167. Latin America Polypeptide Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Polypeptide Drug Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Polypeptide Drug Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Polypeptide Drug Sales by Country (2021-2026) & (Tons) Table 171. Middle East and Africa Polypeptide Drug Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Polypeptide Drug Sales Forecast by Country (2027-2032) & (Tons) Table 173. Middle East and Africa Polypeptide Drug Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Polypeptide Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Polypeptide Drug Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Polypeptide Drug Market Share by Country (2021-2026) Table 177. Middle East and Africa Polypeptide Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Polypeptide Drug Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Polypeptide Drug Distributors List Table 182. Polypeptide Drug Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Polypeptide Drug Image Figure 2. Global Polypeptide Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polypeptide Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Polypeptide Drug Sales (2021-2032) & (Tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (Tons) Figure 7. Oral Administration Image Figure 8. Global Oral Administration Sales YoY Growth (2021-2032) & (Tons) Figure 9. Transdermal Administration Image Figure 10. Global Transdermal Administration Sales YoY Growth (2021-2032) & (Tons) Figure 11. Lung Administration Image Figure 12. Global Lung Administration Sales YoY Growth (2021-2032) & (Tons) Figure 13. Nasal Administration Image Figure 14. Global Nasal Administration Sales YoY Growth (2021-2032) & (Tons) Figure 15. Global Polypeptide Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Polypeptide Drug Market Share by Type 2025 VS 2032 Figure 17. North America Polypeptide Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Polypeptide Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Polypeptide Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Polypeptide Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Polypeptide Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Polypeptide Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Polypeptide Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Polypeptide Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Polypeptide Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Polypeptide Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Polypeptide Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Tumor Drug Image Figure 30. Global Tumor Drug Sales YoY Growth (2021-2032) & (Tons) Figure 31. Digestive System Drugs (Gastrointestinal Type) Image Figure 32. Global Digestive System Drugs (Gastrointestinal Type) Sales YoY Growth (2021-2032) & (Tons) Figure 33. Immunity Regulating Medicine (Allergy Infection and Immune) Image Figure 34. Global Immunity Regulating Medicine (Allergy Infection and Immune) Sales YoY Growth (2021-2032) & (Tons) Figure 35. Urinary System Drug Image Figure 36. Global Urinary System Drug Sales YoY Growth (2021-2032) & (Tons) Figure 37. Bone and Connective Tissue Types (Thyroid hormones Drug) Image Figure 38. Global Bone and Connective Tissue Types (Thyroid hormones Drug) Sales YoY Growth (2021-2032) & (Tons) Figure 39. Gynecologic or Obstetric Drug Image Figure 40. Global Gynecologic or Obstetric Drug Sales YoY Growth (2021-2032) & (Tons) Figure 41. Metabolic Drug (Insulin and Other Hypoglycemic Agents) Image Figure 42. Global Metabolic Drug (Insulin and Other Hypoglycemic Agents) Sales YoY Growth (2021-2032) & (Tons) Figure 43. Global Polypeptide Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Polypeptide Drug Market Share by Application 2025 VS 2032 Figure 45. North America Polypeptide Drug Sales Market Share in Volume by Application in 2025 Figure 46. North America Polypeptide Drug Sales Market Share in Value by Application in 2025 Figure 47. Europe Polypeptide Drug Sales Market Share in Volume by Application in 2025 Figure 48. Europe Polypeptide Drug Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Polypeptide Drug Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Polypeptide Drug Sales Market Share in Value by Application in 2025 Figure 51. Latin America Polypeptide Drug Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Polypeptide Drug Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Polypeptide Drug Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Polypeptide Drug Sales Market Share in Value by Application in 2025 Figure 55. North America Polypeptide Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. North America Polypeptide Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Polypeptide Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Polypeptide Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Polypeptide Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Europe Polypeptide Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Polypeptide Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Polypeptide Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Polypeptide Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 64. Asia-Pacific Polypeptide Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Polypeptide Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Polypeptide Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Polypeptide Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 68. Latin America Polypeptide Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Polypeptide Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Polypeptide Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Polypeptide Drug Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 72. Middle East and Africa Polypeptide Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Polypeptide Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Polypeptide Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Polypeptide Drug Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Polypeptide Drug Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Administration
  • Transdermal Administration
  • Lung Administration
  • Nasal Administration
Applications
  • Tumor Drug
  • Digestive System Drugs (Gastrointestinal Type)
  • Immunity Regulating Medicine (Allergy Infection and Immune)
  • Urinary System Drug
  • Bone and Connective Tissue Types (Thyroid hormones Drug)
  • Gynecologic or Obstetric Drug
  • Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Companies covered
  • Takeda
  • Sanofi
  • Novartis
  • Roche
  • Lilly
  • Ferring Pharmaceuticals
  • AstraZeneca
  • SciClone Pharmaceuticals
  • Merck Serono
  • Ipsen PHarma Biotech
  • Asahi Kasei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polypeptide Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Polypeptide Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Polypeptide Drug Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Oral Administration
  8. 1.3.3 Transdermal Administration
  9. 1.3.4 Lung Administration
  10. 1.3.5 Nasal Administration
  11. 1.4 Global Polypeptide Drug Market Size by Type
  12. 1.4.1 Global Polypeptide Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Polypeptide Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Polypeptide Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Polypeptide Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Polypeptide Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Polypeptide Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Polypeptide Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Polypeptide Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Polypeptide Drug Industry Trends
  2. 2.2 Polypeptide Drug Industry Drivers
  3. 2.3 Polypeptide Drug Industry Opportunities and Challenges
  4. 2.4 Polypeptide Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Polypeptide Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Polypeptide Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Polypeptide Drug Price (2021-2026)
  4. 3.4 Global Polypeptide Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Polypeptide Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Polypeptide Drug Company, Product Type & Application
  7. 3.7 Global Polypeptide Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Polypeptide Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Polypeptide Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Polypeptide Drug Tier 1, Tier 2, and Tier 3
4 Polypeptide Drug Regional Status and Outlook
  1. 4.1 Global Polypeptide Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Polypeptide Drug Historic Market Size by Region
  3. 4.2.1 Global Polypeptide Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Polypeptide Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Polypeptide Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Polypeptide Drug Forecasted Market Size by Region
  7. 4.3.1 Global Polypeptide Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Polypeptide Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Polypeptide Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Polypeptide Drug by Application
  1. 5.1 Polypeptide Drug Market by Application
  2. 5.1.1 Tumor Drug
  3. 5.1.2 Digestive System Drugs (Gastrointestinal Type)
  4. 5.1.3 Immunity Regulating Medicine (Allergy Infection and Immune)
  5. 5.1.4 Urinary System Drug
  6. 5.1.5 Bone and Connective Tissue Types (Thyroid hormones Drug)
  7. 5.1.6 Gynecologic or Obstetric Drug
  8. 5.1.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
  9. 5.2 Global Polypeptide Drug Market Size by Application
  10. 5.2.1 Global Polypeptide Drug Market Size Overview by Application (2021-2032)
  11. 5.2.2 Global Polypeptide Drug Historic Market Size Review by Application (2021-2026)
  12. 5.2.3 Global Polypeptide Drug Forecasted Market Size by Application (2027-2032)
  13. 5.3 Key Regions Market Size by Application
  14. 5.3.1 North America Polypeptide Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.2 Europe Polypeptide Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.3 Asia-Pacific Polypeptide Drug Sales Breakdown by Application (2021-2026)
  17. 5.3.4 South America Polypeptide Drug Sales Breakdown by Application (2021-2026)
  18. 5.3.5 Middle East and Africa Polypeptide Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Polypeptide Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Polypeptide Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Polypeptide Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Polypeptide Drug Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Lilly
  26. 6.5.1 Lilly Company Information
  27. 6.5.2 Lilly Business Overview
  28. 6.5.3 Lilly Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lilly Polypeptide Drug Product Portfolio
  30. 6.5.5 Lilly Recent Developments
  31. 6.6 Ferring Pharmaceuticals
  32. 6.6.1 Ferring Pharmaceuticals Company Information
  33. 6.6.2 Ferring Pharmaceuticals Business Overview
  34. 6.6.3 Ferring Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ferring Pharmaceuticals Polypeptide Drug Product Portfolio
  36. 6.6.5 Ferring Pharmaceuticals Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Polypeptide Drug Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 SciClone Pharmaceuticals
  44. 6.8.1 SciClone Pharmaceuticals Company Information
  45. 6.8.2 SciClone Pharmaceuticals Business Overview
  46. 6.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 SciClone Pharmaceuticals Polypeptide Drug Product Portfolio
  48. 6.8.5 SciClone Pharmaceuticals Recent Developments
  49. 6.9 Merck Serono
  50. 6.9.1 Merck Serono Company Information
  51. 6.9.2 Merck Serono Business Overview
  52. 6.9.3 Merck Serono Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Serono Polypeptide Drug Product Portfolio
  54. 6.9.5 Merck Serono Recent Developments
  55. 6.10 Ipsen PHarma Biotech
  56. 6.10.1 Ipsen PHarma Biotech Company Information
  57. 6.10.2 Ipsen PHarma Biotech Business Overview
  58. 6.10.3 Ipsen PHarma Biotech Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ipsen PHarma Biotech Polypeptide Drug Product Portfolio
  60. 6.10.5 Ipsen PHarma Biotech Recent Developments
  61. 6.11 Asahi Kasei
  62. 6.11.1 Asahi Kasei Company Information
  63. 6.11.2 Asahi Kasei Business Overview
  64. 6.11.3 Asahi Kasei Polypeptide Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Asahi Kasei Polypeptide Drug Product Portfolio
  66. 6.11.5 Asahi Kasei Recent Developments
7 North America by Country
  1. 7.1 North America Polypeptide Drug Sales by Country
  2. 7.1.1 North America Polypeptide Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Polypeptide Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Polypeptide Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Polypeptide Drug Market Size by Country
  6. 7.2.1 North America Polypeptide Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Polypeptide Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Polypeptide Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Polypeptide Drug Sales by Country
  2. 8.1.1 Europe Polypeptide Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Polypeptide Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Polypeptide Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Polypeptide Drug Market Size by Country
  6. 8.2.1 Europe Polypeptide Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Polypeptide Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Polypeptide Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Polypeptide Drug Sales by Country
  2. 9.1.1 Asia-Pacific Polypeptide Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Polypeptide Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Polypeptide Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Polypeptide Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Polypeptide Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Polypeptide Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Polypeptide Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Polypeptide Drug Sales by Country
  2. 10.1.1 South America Polypeptide Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Polypeptide Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Polypeptide Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Polypeptide Drug Market Size by Country
  6. 10.2.1 South America Polypeptide Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Polypeptide Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Polypeptide Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Polypeptide Drug Sales by Country
  2. 11.1.1 Middle East and Africa Polypeptide Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Polypeptide Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Polypeptide Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Polypeptide Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Polypeptide Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Polypeptide Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Polypeptide Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Polypeptide Drug Value Chain Analysis
  2. 12.1.1 Polypeptide Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Polypeptide Drug Production Mode & Process
  7. 12.2 Polypeptide Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Polypeptide Drug Distributors
  10. 12.2.3 Polypeptide Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst